MESTO PUNKTsIONNOY BIOPSII V DIAGNOSTIKE KhRONIChESKIKh DIFFUZNYKh ZABOLEVANIY PEChENI
- Authors: Pavlov C.S1, Glushenkov D.V1, Ivashkin V.T1
-
Affiliations:
- Issue: No 1s (2012)
- Pages: 3-6
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279190
- ID: 279190
Cite item
Open Access
Access granted
Abstract
The article proves necessity for the assessment of necro-inflammation, fibrosis and steatosis in the diagnosis of chronic diffuse liver diseases and in the control of effectiveness of their treatment. The potentials and limitations for the use for this purpose of liver biopsy, and liver elastography and Fibro/ActiTest and FibroMax diagnostic panels as an alternative, are considered. It is emphasized that the use of these non-invasive methods of diagnosis of chronic diffuse liver diseases allows to evaluate the hepatic fibrosis, activity of disease and severity of steatosis without a needle biopsy.
Full Text
References
- Ивашкин В.Т. Болезни печени и желчевыводящих путей: Руководство для врачей. М.: М-Вести, 2005. С. 66-536.
- Bataller R., Brenner D.A. Liver fibrosis. J. Clin. invest. 2005; 115: 209-18.
- Francoise D. Practices of Liver Biopsy in France: Results of Prospective Nationwide Survey. J. Hepatol. 2011; 32(6): 1403-08.
- Brunt E.M. Nonalcoholic steatohepatiatis. Semin Liver Dis. 2011; 24: 3-20.
- Poynard T., Ratziu V., Bedossa P. Appropriateness of liver biopsy. J. Gastroenterol. 2009; 14(543): 8.
- Sandrin L., Fourquet B., Hasquenoph J.M., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound in Medicine and Biology. 2009; 29(12): 1705-13.
- Poynard T. A prospective assessment of the interlaboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comp. Hep. 2008; 2: 3-7.
- Glushenkov D.V., Konovalova O.N., Pavlov Ch.S., et al. Sensitivity and Specificity of Fibro Test in Patients with Chronic Hepatitis C/B at Different Stages of Hepatic Fibrosis. Hepatology international (official journal of the Asian Pacific Association for the study of the liver), june 2008; 2(Supp. 2): Yi -18. S. 48.
- Pavlov Ch., Glushenkov D., Konovalova O., et al. Screening-research CDLD with liver elastography. Liver fibrogenesis common and organ specific mechanisms, EASL: monothematic conference, Petersberg, Germany 2011; S145.
- Pavlov Ch., Glushenkov D., Lobko O., et al. The distribution of patients with chronic hepatitis C (HCV) in the Russian Federation by the stage of liver fibrosis (Data elastometry - a four-year multicenter study) // EASL-AASLD Special Conference on "Therapy of Hepatitis C: Clinical application and drug development", The Czech Republic, Prague, September 14-16/2012, Poster board number: 62. Р. 125.
Supplementary files
